RPC: The company has a sufficient market supply of oseltamivir phosphate capsules and other antiviral flu medications
On January 9th, Jinshi Data reported that RPC stated on the interactive platform that the mainstream anti-influenza product Oseltamivir Phosphate Capsules has been sold by the company for many years and is self-researched and self-produced, currently ensuring market supply. Additionally, for symptoms corresponding to influenza, such as antipyretic and analgesic products like Renhe Ibuprofen; cough relief products like Strong Loquat Syrup and Cough Syrup, these products are all key gold products of the company. Currently, the company's production and sales are normal, and as the year-end holiday approaches, all departments will focus on market demand to fully ensure product supply
